Genprex, Inc. Intellectual Property Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive License Agreement between University of Pittsburgh and Genprex, Inc. for Diabetes Therapy Technologies
License Agreements
Genprex, Inc.
Biotechnology
2025
Second Amendment to Exclusive License Agreement between University of Pittsburgh and Genprex, Inc.
License Agreements
Genprex, Inc.
Biotechnology
2024
Exclusive License Agreement between University of Pittsburgh and Genprex, Inc. for Diabetes Gene Therapy Technology
License Agreements
Genprex, Inc.
Biotechnology
2023
Exclusive License Agreement between University of Pittsburgh and Genprex, Inc. for Diabetes Gene Therapy Technology
License Agreements
Genprex, Inc.
Biotechnology
2023
Exclusive License Agreement between University of Pittsburgh and Genprex, Inc. for Diabetes Therapy Technology
License Agreements
Genprex, Inc.
Biotechnology
2022
First Amendment to Exclusive License Agreement between University of Pittsburgh and Genprex, Inc.
License Agreements
Genprex, Inc.
Biotechnology
2022
Amendment No. 1 to Patent and Technology License Agreement between The University of Texas M. D. Anderson Cancer Center and Genprex, Inc.
License Agreements
Genprex, Inc.
Biotechnology
2021
Patent and Technology License Agreement between The University of Texas System and Genprex, Inc.
License Agreements
Genprex, Inc.
Biotechnology
TX
2020
Exclusive License Agreement between University of Pittsburgh and Genprex, Inc. for Diabetes Therapy Patent Rights
License Agreements
Genprex, Inc.
Biotechnology
2020
Technology Sublicense Agreement between Convergen LifeSciences, Inc. and Introgen Research Institute, Inc.
License Agreements
Genprex, Inc.
Biotechnology
2017
Technology License Agreement between Introgen Research Institute, Inc. and P53, Inc. (February 26, 2010)
License Agreements
Genprex, Inc.
Biotechnology
TX
2017
Technology Sublicense Agreement between Introgen Therapeutics, Inc. and Introgen Research Institute, Inc.
License Agreements
Genprex, Inc.
Biotechnology
2017
Amendment No. 3 to Patent and Technology License Agreement between The University of Texas M.D. Anderson Cancer Center and Introgen Therapeutics, Inc.
License Agreements
Genprex, Inc.
Biotechnology
2017
Patent and Technology License Agreement between University of Texas System, M.D. Anderson Cancer Center, and Intron Therapeutics, Inc.
License Agreements
Genprex, Inc.
Biotechnology
TX
2017